article thumbnail

Blueprint boosts Ayvakit peak sales estimate to $2B as key rare disease expansion accelerates

Fierce Pharma

With another quarter exceeding analysts’ expectations, Blueprint Medicines has raised its peak sales estimate for rare disease drug Ayvakit to $2 billion. With another quarter exceeding analysts’ expectations, Blueprint Medicines has raised its peak sales estimate for rare disease drug Ayvakit to $2 billion.

Sales 238
article thumbnail

FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic

Fierce Pharma

FDA unleashes multiple warning letters targeting insanitary manufacturing and online sales of unapproved Mounjaro, Ozempic fkansteiner Wed, 02/14/2024 - 05:10

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Who's No. 1? With $25B in sales, Merck's Keytruda looks to be the top-selling drug of 2023

Fierce Pharma

With Merck reporting a whopping $25 billion sales haul for | With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023. billion in 2022 and $55.1 billion in 2021.

Sales 291
article thumbnail

Novartis dials up midterm sales projection, fleshes out Kisqali's $7B-plus goal

Fierce Pharma

Novartis is getting more optimistic about its midterm sales potential, thanks to bullish estimates for some blockbuster drugs. Novartis is getting more optimistic about its midterm sales potential, thanks to bullish estimates for some blockbuster drugs, including Entresto and Kisqali.

Sales 260
article thumbnail

The Ultimate Guide to Sales Outreach

Sales outreach is an art and a science. By the time you reach the end of our guide, you’ll be a sales outreach pro. The art is what you bring to the table—your flair for conversation, your work ethic, your dedication. We bring the science—proven tactics, strategies, and methods that really work.

article thumbnail

Despite Roche's sharp COVID sales decline, eye drug Vabysmo powers major revenue win, CEO says

Fierce Pharma

Despite a sharp decline in COVID-related sales, the company was able to grow overall revenues | As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023. As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023.

Sales 245
article thumbnail

As Catalent prepares to join Novo family, CDMO's sales continue to slide

Fierce Pharma

Despite some turbulence at Catalent, including an 11% sales drop for the quarter, investors still seem to be buzzed about the stock after this week’s announcement that Novo Holdings is buying out the CDMO for $16.5

Sales 228
article thumbnail

B2B Pocket Playbook: End-to-End Guide to Sales Enablement

Sales enablement is the strategic process of providing sales teams with the content, guidance, and mentorship needed to engage targeted buyers. It’s all about equipping sales professionals with the tools they need to put their best-selling foot forward. Get started today.

article thumbnail

4 AI Hacks to Make Sales Teams More Efficient

Over the last two years, there’s been a 76 percent increase in AI adoption across sales organizations. For sales teams, AI opens up a world of new possibilities, including automating outreach, identifying best-fit buyers, and keeping CRMs flush with fresh data.

article thumbnail

The Impact of Direct Dials on Sales Productivity

Often, sales reps who fail to hit the phones hard are left wondering how they missed their quota. While dialing away at targeted prospects, it’s important for them to remember that not all sales outreach is created equal. How can you (and your sales team) benefit from this eBook?

article thumbnail

The Best Sales Forecasting Models for Weathering Your Goals

Every sales forecasting model has a different strength and predictability method. Your future sales forecast? It’s recommended to test out which one is best for your team. This way, you’ll be able to further enhance – and optimize – your newly-developed pipeline. Sunny skies (and success) are just ahead!

article thumbnail

16 Go-to-Market Plays for Your Entire Sales Funnel

Nurturing leads through your sales funnel is a daunting task for many business development teams, especially at the scale required to achieve lofty growth goals. That’s why we’ve gathered some of the best go-to-market plays from our own B2B sales and marketing pros and packaged them here for you.

article thumbnail

Outrun Your Competition: Best Practices for Accelerating Sales Processes

Longer sales cycles. Every go-to-market team knows the frustrations that come from a drawn-out sales process. Larger buying committees. Slow-moving compliance reviews. How can you speed it up? By building a modern GTM motion that uses data, automation, and proven best practices to unlock insights, engage customers, and win faster.

article thumbnail

The 2019 Technographic Data Report for B2B Sales Organizations

In this report, ZoomInfo substantiates the assertion that technographic data is a vital resource for sales teams. The reason for this is simple—sales teams value technographic data because it makes essential selling activities easier and more efficient. In fact, the majority of respondents agree—with 72.3%

article thumbnail

100 Pipeline Plays: The Modern Sales Playbook

Meet your modern sales playbook - See how high-performing sales and marketing teams increase pipeline year-over-year. For the first time, we’re sharing the winning plays that took us from scrappy startup to a publicly traded company. Use our proven data-driven plays to grow your pipeline and crush your revenue targets.